- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic pouchitis
- Meeting Date: July 2024
- Public Summary Document (PSD) July 2024 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) July 2024 PBAC Meeting - (Word 285KB)
Vedolizumab – July 2024
Vedolizumab; Powder for injection 300 mg; Entyvio®
Last updated
30 May 2025